ethyl 4-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-4-oxobutyrate, 97.0%, 1g

2-oxo-1-(pyridin-2-ylmethyl)-1,2-dihydropyridine-3-carboxylic acid hydrochloride, 95.0%, 250mg

3-(5-Fluoro-2-methoxyphenyl)-1-propene, 97.0%, 2g

ethyl 2,6-dichloro-3-methylpyridine-4-carboxylate, 97.0%, 250mg

4-Chloro-8-(trifluoromethyl)quinoline>98.0%(GC)1g

2-Bromo-3-nitrobenzonitrile, 97%, 250mg

7-Bromo-2,4-dichloro-8-fluoroquinazoline, 97%, 1g

2,5-Difluoro-nicotinic acid, 95.0%, 2.5g

Sodium 1-Naphthalenesulfonate>98.0%(HPLC)(T)100g

9-amino-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-5-one, 95.0%, 2g

5-(Difluoromethoxy)-6-methylpyridin-2-amine, 98%, 250mg

Sodium 1-amino-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate, 95%, 10g

5-Bromo-1-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 5g